LIPOCINE INC. Gain (Loss) on Extinguishment of Debt
LIPOCINE INC. (LPCN) reported Gain (Loss) on Extinguishment of Debt of $234.80 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2022-03-09
- LIPOCINE INC. gain (loss) on extinguishment of debt for fiscal 2020 was $234.80K.
- LIPOCINE INC. gain (loss) on extinguishment of debt for fiscal 2019 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|
| 2020-12-31 | $234.80K 10-K · filed 2022-03-09 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |